首页 > 最新文献

Future microbiology最新文献

英文 中文
Emerging pathogens Aerococcus urinae and Aerococcus sanguinicola from a Canadian tertiary care hospital. 加拿大一家三甲医院新出现的病原体尿道气球菌(Aerococcus urinae)和血尿气球菌(Aerococcus sanguinicola)。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-07 DOI: 10.1080/17460913.2024.2383503
Pramath Kakodkar, Joel Scott, Javera Tariq, Liqin Du, Fang Wu, Ninad Mehta, Camille Hamula

Background: Aerococcus urinae and Aerococcus sanguinicola are emerging pathogens linked with urinary tract infections. We present a case series of A. urinae and A. sanguinicola isolates characterizing the spectrum of clinical presentation, microbiological characteristics and antimicrobial sensitivities.Methods: Retrospective chart review was performed on patients who grew positive cultures for A. urinae and A. sanguinicola identified on MALDI-TOF in Saskatchewan from January to June 2023. Demographic and clinical variables, antimicrobial susceptibility and prescription were documented.Results: This cohort (n = 115) had a median age 82 years. A. urinae and A. sanguinicola infections spanned from urinary tract infection (n = 96) to urosepsis (n = 6). These infections were predominantly monomicrobial (73.9%) and were susceptible to ceftriaxone, penicillin G and vancomycin. Antimicrobials were seldom prescribed within the urinary tract infection cohort (31.2%).Conclusion: Untreated A. urinae and A. sanguinicola infections can precipitate into urosepsis. The reported antimicrobial susceptibility for these Aerococcus isolates should be utilized to provide appropriate antimicrobial coverage.

背景:尿道球菌(Aerococcus urinae)和桑吉尼球菌(Aerococcus sanguinicola)是与尿路感染有关的新兴病原体。我们介绍了一系列尿道气球菌和膀胱气球菌分离病例,这些病例具有不同的临床表现、微生物学特征和抗菌药敏感性。研究方法对 2023 年 1 月至 6 月期间在萨斯喀彻温省通过 MALDI-TOF 鉴定出的泌尿系统甲型肝炎病毒(A. urinae)和盘尾丝虫病病毒(A. sanguinicola)培养呈阳性的患者进行回顾性病历审查。记录了人口统计学和临床变量、抗菌药敏感性和处方。结果这组病例(n = 115)的中位年龄为 82 岁。A.urinae和A.sanguinicola感染范围从尿路感染(96人)到尿毒症(6人)。这些感染主要为单微生物感染(73.9%),对头孢曲松、青霉素 G 和万古霉素敏感。尿路感染患者很少使用抗菌药物(31.2%)。结论未经治疗的 A. urinae 和 A. sanguinicola 感染会诱发尿毒症。应根据已报告的抗菌药物敏感性,为这些分离出的粪球菌提供适当的抗菌药物。
{"title":"Emerging pathogens <i>Aerococcus urinae</i> and <i>Aerococcus sanguinicola</i> from a Canadian tertiary care hospital.","authors":"Pramath Kakodkar, Joel Scott, Javera Tariq, Liqin Du, Fang Wu, Ninad Mehta, Camille Hamula","doi":"10.1080/17460913.2024.2383503","DOIUrl":"10.1080/17460913.2024.2383503","url":null,"abstract":"<p><p><b>Background:</b> <i>Aerococcus urinae</i> and <i>Aerococcus sanguinicola</i> are emerging pathogens linked with urinary tract infections. We present a case series of <i>A. urinae</i> and <i>A. sanguinicola</i> isolates characterizing the spectrum of clinical presentation, microbiological characteristics and antimicrobial sensitivities.<b>Methods:</b> Retrospective chart review was performed on patients who grew positive cultures for <i>A. urinae</i> and <i>A. sanguinicola</i> identified on MALDI-TOF in Saskatchewan from January to June 2023. Demographic and clinical variables, antimicrobial susceptibility and prescription were documented.<b>Results:</b> This cohort (n = 115) had a median age 82 years. <i>A. urinae</i> and <i>A. sanguinicola</i> infections spanned from urinary tract infection (n = 96) to urosepsis (n = 6). These infections were predominantly monomicrobial (73.9%) and were susceptible to ceftriaxone, penicillin G and vancomycin. Antimicrobials were seldom prescribed within the urinary tract infection cohort (31.2%).<b>Conclusion:</b> Untreated <i>A. urinae</i> and <i>A. sanguinicola</i> infections can precipitate into urosepsis. The reported antimicrobial susceptibility for these <i>Aerococcus</i> isolates should be utilized to provide appropriate antimicrobial coverage.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"1321-1332"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next-generation microbiome therapeutics: why it is important to consider the space left in the wake of antibiotic treatment. 下一代微生物组疗法:为什么必须考虑抗生素治疗后留下的空间?
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-11-21 DOI: 10.1080/17460913.2024.2421113
Olivia G King, Victoria Horrocks, Alexander Y G Yip, Julie A K McDonald
{"title":"Next-generation microbiome therapeutics: why it is important to consider the space left in the wake of antibiotic treatment.","authors":"Olivia G King, Victoria Horrocks, Alexander Y G Yip, Julie A K McDonald","doi":"10.1080/17460913.2024.2421113","DOIUrl":"10.1080/17460913.2024.2421113","url":null,"abstract":"","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"1515-1518"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomaterial-based drug-delivery system as an aid to antimicrobial photodynamic therapy in treating oral biofilm. 基于纳米材料的给药系统作为抗菌光动力疗法的辅助手段,用于治疗口腔生物膜。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-04-29 DOI: 10.2217/fmb-2023-0259
Guanwen Sun, Shan Huang, Shaofeng Wang, Yijun Li

Diverse microorganisms live as biofilm in the mouth accounts for oral diseases and treatment failure. For decades, the prevention and treatment of oral biofilm is a global challenge. Antimicrobial photodynamic therapy (aPDT) holds promise for oral biofilm elimination due to its several traits, including broad-spectrum antimicrobial capacity, lower possibility of resistance and low cytotoxicity. However, the physicochemical properties of photosensitizers and the biological barrier of oral biofilm have limited the efficiency of aPDT. Nanomaterials has been used to fabricate nanocarriers to improve photosensitizer properties and thus enhance antimicrobial effect. In this review, we have discussed the challenges of aPDT used in dentistry, categorized the nanomaterial-delivery system and listed the possible mechanisms involved in nanomaterials when enhancing aPDT effect.

多种微生物以生物膜的形式存活于口腔中,导致口腔疾病和治疗失败。几十年来,口腔生物膜的预防和治疗一直是一项全球性挑战。抗菌光动力疗法(aPDT)具有广谱抗菌能力、较低的耐药性和低细胞毒性等特点,有望消除口腔生物膜。然而,光敏剂的物理化学特性和口腔生物膜的生物屏障限制了光敏剂疗法的效率。纳米材料被用来制造纳米载体,以改善光敏剂的特性,从而提高抗菌效果。在这篇综述中,我们讨论了牙科中使用的光动力杀菌剂所面临的挑战,对纳米材料给药系统进行了分类,并列出了纳米材料在增强光动力杀菌剂效果时可能涉及的机制。
{"title":"Nanomaterial-based drug-delivery system as an aid to antimicrobial photodynamic therapy in treating oral biofilm.","authors":"Guanwen Sun, Shan Huang, Shaofeng Wang, Yijun Li","doi":"10.2217/fmb-2023-0259","DOIUrl":"10.2217/fmb-2023-0259","url":null,"abstract":"<p><p>Diverse microorganisms live as biofilm in the mouth accounts for oral diseases and treatment failure. For decades, the prevention and treatment of oral biofilm is a global challenge. Antimicrobial photodynamic therapy (aPDT) holds promise for oral biofilm elimination due to its several traits, including broad-spectrum antimicrobial capacity, lower possibility of resistance and low cytotoxicity. However, the physicochemical properties of photosensitizers and the biological barrier of oral biofilm have limited the efficiency of aPDT. Nanomaterials has been used to fabricate nanocarriers to improve photosensitizer properties and thus enhance antimicrobial effect. In this review, we have discussed the challenges of aPDT used in dentistry, categorized the nanomaterial-delivery system and listed the possible mechanisms involved in nanomaterials when enhancing aPDT effect.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"741-759"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro and in vivo inhibitory effects of the Sanghuang mushroom extracts against Candida albicans. 三黄菇提取物对白色念珠菌的体外和体内抑制作用。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-21 DOI: 10.1080/17460913.2024.2352269
Jiahui Du, Shuqing Jin, Ying Zhang, Wei Qiu, Yahui Dong, Yan Liu, Dengke Yin, Ye Yang, Weifang Xu

Aim: To explore the antifungal potential of Sanghuang mushroom, a traditional Chinese medicine. Materials & methods: The antifungal properties and the potential mechanism of Sanghuang mushroom extracts against Candida albicans were studied in vitro and in vivo. Results: Sanghuang mushroom extracts inhibited the biofilm formation, increased the cell membrane permeability and promoted cell apoptosis of C. albicans in vitro. In a murine model of vulvovaginal candidiasis, Sanghuang mushroom extracts reduced the vaginal fungal load, improved inflammatory cell infiltration and downregulated the expression of TNF-α, IL-1β and IL-6. Untargeted metabolomic analysis suggested the presence of ten antifungal components in Sanghuang mushroom extracts. Conclusion: Sanghuang mushroom extracts showed promise as antifungal agent against candidiasis, with potential therapeutic implications.

目的:探索中药三黄菇的抗真菌潜力。材料与方法:在体外和体内研究三黄菇提取物对白色念珠菌的抗真菌特性和潜在机制。结果在体外,三黄菇提取物能抑制白色念珠菌生物膜的形成,增加细胞膜的通透性,促进细胞凋亡。在小鼠外阴阴道念珠菌病模型中,三黄菇提取物降低了阴道真菌负荷,改善了炎症细胞浸润,并下调了 TNF-α、IL-1β 和 IL-6 的表达。非靶向代谢组分析表明,三黄菇提取物中含有十种抗真菌成分。结论三黄菇提取物有望成为抗念珠菌病的抗真菌剂,具有潜在的治疗意义。
{"title":"<i>In vitro</i> and <i>in vivo</i> inhibitory effects of the Sanghuang mushroom extracts against <i>Candida albicans</i>.","authors":"Jiahui Du, Shuqing Jin, Ying Zhang, Wei Qiu, Yahui Dong, Yan Liu, Dengke Yin, Ye Yang, Weifang Xu","doi":"10.1080/17460913.2024.2352269","DOIUrl":"10.1080/17460913.2024.2352269","url":null,"abstract":"<p><p><b>Aim:</b> To explore the antifungal potential of Sanghuang mushroom, a traditional Chinese medicine. <b>Materials & methods:</b> The antifungal properties and the potential mechanism of Sanghuang mushroom extracts against <i>Candida albicans</i> were studied <i>in vitro</i> and <i>in vivo</i>. <b>Results:</b> Sanghuang mushroom extracts inhibited the biofilm formation, increased the cell membrane permeability and promoted cell apoptosis of <i>C. albicans in vitro</i>. In a murine model of vulvovaginal candidiasis, Sanghuang mushroom extracts reduced the vaginal fungal load, improved inflammatory cell infiltration and downregulated the expression of TNF-α, IL-1β and IL-6. Untargeted metabolomic analysis suggested the presence of ten antifungal components in Sanghuang mushroom extracts. <b>Conclusion:</b> Sanghuang mushroom extracts showed promise as antifungal agent against candidiasis, with potential therapeutic implications.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"983-996"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biosurfactant complexed with arginine has antibiofilm activity against methicillin-resistant Staphylococcus aureus. 与精氨酸复配的生物表面活性剂对耐甲氧西林金黄色葡萄球菌具有抗生物膜活性。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-12 DOI: 10.2217/fmb-2023-0271
Fatima Daiana Dias Barroso, Lisandra Juvêncio da Silva, Helaine Almeida Queiroz, Lívia Gurgel do Amaral Valente Sá, Anderson Ramos da Silva, Cecília Rocha da Silva, João Batista de Andrade Neto, Bruno Coêlho Cavalcanti, Manoel Odorico de Moraes, Aurora Pinazo, Lourdes Pérez, Hélio Vitoriano Nobre Júnior

Aim: The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant Staphylococcus aureus (MRSA). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. Result: RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. Conclusion: RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant S. aureus biofilms.

目的:本研究调查了鼠李糖脂与精氨酸复合物(RLMIX_Arg)对耐甲氧西林金黄色葡萄球菌(MRSA)浮游细胞和生物膜的抗菌效果。方法:药敏试验采用临床与实验室标准研究所(Clinical & Laboratory Standards Institute)的方案进行:使用了 M07-A10、棋盘试验、平板和导管中的生物膜以及流式细胞仪。结果:RLMIX_Arg 与奥沙西林具有杀菌和协同活性。在亚抑制浓度下,RLMIX_Arg 可抑制平板上 MRSA 生物膜的形成,并对外周静脉导管中的 MRSA 具有抗生物膜作用。浸渍了 RLMIX_Arg 的导管可减少 MRSA 生物膜的形成。结论:RLMIX_Arg 具有应用于预防耐甲氧西林金黄色葡萄球菌生物膜感染的潜力。
{"title":"Biosurfactant complexed with arginine has antibiofilm activity against methicillin-resistant <i>Staphylococcus aureus</i>.","authors":"Fatima Daiana Dias Barroso, Lisandra Juvêncio da Silva, Helaine Almeida Queiroz, Lívia Gurgel do Amaral Valente Sá, Anderson Ramos da Silva, Cecília Rocha da Silva, João Batista de Andrade Neto, Bruno Coêlho Cavalcanti, Manoel Odorico de Moraes, Aurora Pinazo, Lourdes Pérez, Hélio Vitoriano Nobre Júnior","doi":"10.2217/fmb-2023-0271","DOIUrl":"10.2217/fmb-2023-0271","url":null,"abstract":"<p><p><b>Aim:</b> The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). <b>Methodology:</b> Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. <b>Result:</b> RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. <b>Conclusion:</b> RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant <i>S. aureus</i> biofilms.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"667-679"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial synergies and antagonisms affecting Pseudomonas aeruginosa virulence in the human lung, skin and intestine. 影响人肺、皮肤和肠道中铜绿假单胞菌毒力的细菌协同作用和拮抗剂。
IF 3.1 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2023-10-16 DOI: 10.2217/fmb-2022-0155
Izel Ungor, Yiorgos Apidianakis

Pseudomonas aeruginosa requires a significant breach in the host defense to cause an infection. While its virulence factors are well studied, its tropism cannot be explained only by studying its interaction with the host. Why are P. aeruginosa infections so rare in the intestine compared with the lung and skin? There is not enough evidence to claim specificity in virulence factors deployed by P. aeruginosa in each anatomical site, and host physiology differences between the lung and the intestine cannot easily explain the observed differences in virulence. This perspective highlights a relatively overlooked parameter in P. aeruginosa virulence, namely, potential synergies with bacteria found in the human skin and lung, as well as antagonisms with bacteria of the human intestine.

铜绿假单胞菌需要宿主防御的重大突破才能引起感染。虽然它的毒力因子已经得到了很好的研究,但不能仅仅通过研究它与宿主的相互作用来解释它的嗜性。为什么与肺部和皮肤相比,肠道中的铜绿假单胞菌感染如此罕见?没有足够的证据表明铜绿假单胞菌在每个解剖部位部署的毒力因子具有特异性,肺和肠之间的宿主生理学差异也无法轻易解释观察到的毒力差异。这一观点突出了铜绿假单胞菌毒力中一个相对被忽视的参数,即与人类皮肤和肺部细菌的潜在协同作用,以及与人类肠道细菌的拮抗作用。
{"title":"Bacterial synergies and antagonisms affecting <i>Pseudomonas aeruginosa</i> virulence in the human lung, skin and intestine.","authors":"Izel Ungor, Yiorgos Apidianakis","doi":"10.2217/fmb-2022-0155","DOIUrl":"10.2217/fmb-2022-0155","url":null,"abstract":"<p><p><i>Pseudomonas aeruginosa</i> requires a significant breach in the host defense to cause an infection. While its virulence factors are well studied, its tropism cannot be explained only by studying its interaction with the host. Why are <i>P. aeruginosa</i> infections so rare in the intestine compared with the lung and skin? There is not enough evidence to claim specificity in virulence factors deployed by <i>P. aeruginosa</i> in each anatomical site, and host physiology differences between the lung and the intestine cannot easily explain the observed differences in virulence. This perspective highlights a relatively overlooked parameter in <i>P. aeruginosa</i> virulence, namely, potential synergies with bacteria found in the human skin and lung, as well as antagonisms with bacteria of the human intestine.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"141-155"},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41234667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiparasitic stewardship: a call to action. 抗寄生虫管理:行动呼吁。
IF 3.1 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-02-13 DOI: 10.2217/fmb-2023-0218
Sören L Becker, Sophie Schneitler

Tweetable abstract There is an urgent need to consider antiparasitic drugs in global efforts to achieve and implement equitable and sustainable antimicrobial stewardship initiatives worldwide.

Tweetable 摘要 在全球努力实现和实施公平、可持续的抗菌药物管理举措的过程中,迫切需要考虑抗寄生虫药物。
{"title":"Antiparasitic stewardship: a call to action.","authors":"Sören L Becker, Sophie Schneitler","doi":"10.2217/fmb-2023-0218","DOIUrl":"10.2217/fmb-2023-0218","url":null,"abstract":"<p><p>Tweetable abstract There is an urgent need to consider antiparasitic drugs in global efforts to achieve and implement equitable and sustainable antimicrobial stewardship initiatives worldwide.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":"19 ","pages":"5-8"},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum. 目前治疗引起新生儿眼炎的耐药淋病奈瑟菌的替代疗法。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-21 DOI: 10.2217/fmb-2023-0251
Praveen Belagal

Ophthalmia neonatorum is a microbial contraction, damaging eyesight, occurring largely among neonates. Infants are particularly vulnerable to bacterial infections acquired during birth from infected mothers, especially from Neisseria gonorrhoeae and Chlamydia trachomatis. Over the decades, N. gonorrhoeae is alarmingly developing a resistance to most antibiotics currently prescribed. To counter this challenge, it is imperative to find potent and cost-effective therapeutic agents for prophylaxis and treatment, to which the N. gonorrhoeae cannot easily develop resistance. This review showcases alternate therapies such as antimicrobial-fatty acids, -peptides, -nano-formulations etc., currently evident against N. gonorrhoeae-mediated ophthalmia neonatorum, which remains a major cause of ocular morbidity, blindness and even death among neonates in developing countries.

新生儿眼炎是一种损害视力的微生物感染,主要发生在新生儿中。婴儿在出生时特别容易受到受感染母亲的细菌感染,尤其是淋病奈瑟菌和沙眼衣原体。几十年来,淋病奈瑟菌对目前处方中的大多数抗生素产生了惊人的抗药性。为了应对这一挑战,当务之急是找到淋球菌不易产生耐药性的强效且具有成本效益的预防和治疗药物。淋病引发的新生儿眼炎仍是发展中国家新生儿眼部发病、失明甚至死亡的主要原因,本综述展示了目前针对淋病引发的新生儿眼炎的其他疗法,如抗菌脂肪酸、肽、纳米制剂等。
{"title":"Current alternative therapies for treating drug-resistant <i>Neisseria gonorrhoeae</i> causing ophthalmia neonatorum.","authors":"Praveen Belagal","doi":"10.2217/fmb-2023-0251","DOIUrl":"10.2217/fmb-2023-0251","url":null,"abstract":"<p><p>Ophthalmia neonatorum is a microbial contraction, damaging eyesight, occurring largely among neonates. Infants are particularly vulnerable to bacterial infections acquired during birth from infected mothers, especially from <i>Neisseria gonorrhoeae</i> and <i>Chlamydia trachomatis</i>. Over the decades, <i>N. gonorrhoeae</i> is alarmingly developing a resistance to most antibiotics currently prescribed. To counter this challenge, it is imperative to find potent and cost-effective therapeutic agents for prophylaxis and treatment, to which the <i>N. gonorrhoeae</i> cannot easily develop resistance. This review showcases alternate therapies such as antimicrobial-fatty acids, -peptides, -nano-formulations etc., currently evident against <i>N. gonorrhoeae</i>-mediated ophthalmia neonatorum, which remains a major cause of ocular morbidity, blindness and even death among neonates in developing countries.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"631-647"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of silver vanadate on the antibiofilm, adhesion and biocompatibility properties of denture adhesive. 钒酸银对义齿粘合剂抗生物膜、粘附性和生物相容性的影响
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-03 DOI: 10.2217/fmb-2023-0227
Graziele C Alvim, Viviane de C Oliveira, Andréa C Dos Reis, Marco A Schiavon, Marcelo R Pinto, Marcos V da Silva, César P Lepri, Denise T de Castro

Aim: To evaluate the biological and mechanical properties of an adhesive with nanostructured silver vanadate (AgVO3). Materials & methods: Specimens in poly(methyl methacrylate) (PMMA) were treated with Ultra Corega Cream (UCCA) denture adhesive with or without AgVO3. Biofilms of Candida albicans, Candida glabrata and Streptococcus mutans were grown and the viable cells counted. Fluorescence microscopy was used. The viability of the VERO cell and adhesive strength were evaluated. Results: All concentrations of AgVO3 reduced the biofilm formation and showed no cytotoxic effect. At 5 min and 24 h, UCCA with 5 and 10% AgVO3 showed better performance, respectively. Conclusion: AgVO3 promoted the antibiofilm activity of the adhesive, with a positive effect on the adhesive strength, and was biocompatible.

目的:评估纳米结构钒酸银(AgVO3)粘合剂的生物和机械特性。材料与方法:使用含或不含 AgVO3 的 Ultra Corega Cream (UCCA) 义齿粘合剂处理聚甲基丙烯酸甲酯(PMMA)试样。培养白色念珠菌、光滑念珠菌和变异链球菌的生物膜,并对存活细胞进行计数。使用荧光显微镜观察。对 VERO 细胞的存活率和粘合强度进行了评估。结果:所有浓度的 AgVO3 都能减少生物膜的形成,且无细胞毒性作用。在 5 分钟和 24 小时内,含有 5%和 10%AgVO3的 UCCA 分别显示出更好的性能。结论AgVO3 提高了粘合剂的抗生物膜活性,对粘合强度有积极影响,而且具有生物相容性。
{"title":"Effect of silver vanadate on the antibiofilm, adhesion and biocompatibility properties of denture adhesive.","authors":"Graziele C Alvim, Viviane de C Oliveira, Andréa C Dos Reis, Marco A Schiavon, Marcelo R Pinto, Marcos V da Silva, César P Lepri, Denise T de Castro","doi":"10.2217/fmb-2023-0227","DOIUrl":"10.2217/fmb-2023-0227","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the biological and mechanical properties of an adhesive with nanostructured silver vanadate (AgVO<sub>3</sub>). <b>Materials & methods:</b> Specimens in poly(methyl methacrylate) (PMMA) were treated with Ultra Corega Cream (UCCA) denture adhesive with or without AgVO<sub>3</sub>. Biofilms of <i>Candida albicans</i>, <i>Candida glabrata</i> and <i>Streptococcus mutans</i> were grown and the viable cells counted. Fluorescence microscopy was used. The viability of the VERO cell and adhesive strength were evaluated. <b>Results:</b> All concentrations of AgVO<sub>3</sub> reduced the biofilm formation and showed no cytotoxic effect. At 5 min and 24 h, UCCA with 5 and 10% AgVO<sub>3</sub> showed better performance, respectively. <b>Conclusion:</b> AgVO<sub>3</sub> promoted the antibiofilm activity of the adhesive, with a positive effect on the adhesive strength, and was biocompatible.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"655-665"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capabilities of GPT-4o and Gemini 1.5 Pro in Gram stain and bacterial shape identification. GPT-4o 和 Gemini 1.5 Pro 在革兰氏染色和细菌形状鉴定方面的能力。
IF 2.5 4区 生物学 Q3 MICROBIOLOGY Pub Date : 2024-01-01 Epub Date: 2024-07-29 DOI: 10.1080/17460913.2024.2381967
Joya-Rita Hindy, Tarek Souaid, Christopher S Kovacs

Aim: Assessing the visual accuracy of two large language models (LLMs) in microbial classification.Materials & methods: GPT-4o and Gemini 1.5 Pro were evaluated in distinguishing Gram-positive from Gram-negative bacteria and classifying them as cocci or bacilli using 80 Gram stain images from a labeled database.Results: GPT-4o achieved 100% accuracy in identifying simultaneously Gram stain and shape for Clostridium perfringens, Pseudomonas aeruginosa and Staphylococcus aureus. Gemini 1.5 Pro showed more variability for similar bacteria (45, 100 and 95%, respectively). Both LLMs failed to identify both Gram stain and bacterial shape for Neisseria gonorrhoeae. Cumulative accuracy plots indicated that GPT-4o consistently performed equally or better in every identification, except for Neisseria gonorrhoeae's shape.Conclusion: These results suggest that these LLMs in their unprimed state are not ready to be implemented in clinical practice and highlight the need for more research with larger datasets to improve LLMs' effectiveness in clinical microbiology.

目的:评估两种大型语言模型(LLM)在微生物分类中的视觉准确性。材料与方法:使用标注数据库中的 80 张革兰氏染色图像,评估 GPT-4o 和 Gemini 1.5 Pro 在区分革兰氏阳性菌和革兰氏阴性菌以及将其分类为球菌或杆菌方面的能力。结果显示GPT-4o 在同时识别产气荚膜梭菌、铜绿假单胞菌和金黄色葡萄球菌的革兰氏染色和形状方面达到了 100% 的准确率。Gemini 1.5 Pro 对类似细菌的识别率差异更大(分别为 45%、100% 和 95%)。两种 LLM 都无法识别淋病奈瑟菌的革兰氏染色和细菌形态。累积准确度图显示,除淋病奈瑟菌的形状外,GPT-4o 在每种鉴定中的表现都相同或更好。结论这些结果表明,这些 LLMs 在未经预处理的状态下还不能应用于临床实践,因此需要对更大的数据集进行更多的研究,以提高 LLMs 在临床微生物学中的有效性。
{"title":"Capabilities of GPT-4o and Gemini 1.5 Pro in Gram stain and bacterial shape identification.","authors":"Joya-Rita Hindy, Tarek Souaid, Christopher S Kovacs","doi":"10.1080/17460913.2024.2381967","DOIUrl":"10.1080/17460913.2024.2381967","url":null,"abstract":"<p><p><b>Aim:</b> Assessing the visual accuracy of two large language models (LLMs) in microbial classification.<b>Materials & methods:</b> GPT-4o and Gemini 1.5 Pro were evaluated in distinguishing Gram-positive from Gram-negative bacteria and classifying them as cocci or bacilli using 80 Gram stain images from a labeled database.<b>Results:</b> GPT-4o achieved 100% accuracy in identifying simultaneously Gram stain and shape for <i>Clostridium perfringens</i>, <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>. Gemini 1.5 Pro showed more variability for similar bacteria (45, 100 and 95%, respectively). Both LLMs failed to identify both Gram stain and bacterial shape for <i>Neisseria gonorrhoeae</i>. Cumulative accuracy plots indicated that GPT-4o consistently performed equally or better in every identification, except for <i>Neisseria gonorrhoeae's</i> shape.<b>Conclusion:</b> These results suggest that these LLMs in their unprimed state are not ready to be implemented in clinical practice and highlight the need for more research with larger datasets to improve LLMs' effectiveness in clinical microbiology.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"1283-1292"},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1